Keros Therapeutics Announces the First Patient Dosing in the Phase 3 RENEW Clinical Trial of Elritercept
Milestone payment of $10 million triggered under the global license agreement with TakedaLEXINGTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) --...
Year: 2025
KFSHRC Performs World’s First Robotic-Assisted BiVAD Implantation
A minimally invasive robotic surgery offers a life-saving option for high-risk patients who cannot undergo transplants or traditional open-heart procedures...
Peptides For Muscle Growth: How Oral Legal Peptides by Crazy Bulk Set New Benchmark For Bodybuilding Supplements and Muscle Building Results
Discover how CrazyBulk’s oral legal peptides and SARMs stacks are redefining muscle building supplements in 2025. Explore science-backed, gym-proven solutions...
Repligen to Report Second Quarter 2025 Financial Results
Webcast and Conference Call to Be Held Tuesday, July 29, 2025, at 8:30 a.m. ETWALTHAM, Mass., July 17, 2025 (GLOBE...
Velocity Clinical Research Partners with Palantir to Solve Clinical Trials’ Payment Headache
Raghu Punnamraju, Velocity Clinical Research Chief Technology Officer Raghu Punnamraju, Velocity Clinical Research Chief Technology Officer DURHAM, N.C., July 17,...
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases...
Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture
Castle earns recognition as a national Healthcare Industry Top Workplace, an Arizona Top Workplace and receives five Top Workplaces Culture...
Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum – Crafted for Everyone Who Loves a Great Drink
BRECKENRIDGE, Colo., July 17, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands,...
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board...
I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health
Acquisition provides I-Mab with upstream rights to CLDN18.2 parental antibody for use in bispecific and multi-specific applications Acquisition eliminates all...
BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes
The Company welcomes CMS’ efforts to reform skin substitute payment policy and will continue to engage with CMS and other...
Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call
ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will...
Ocugen to Host Conference Call on Friday, August 1 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2025 Financial Results
MALVERN, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader...
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
WAYNE, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second...
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
Company to participate in investor conferences in July and AugustVANCOUVER, British Columbia, July 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc....
Immuron – FY25 global sales exceed projection, up 49% on prior year
Sales Highlights (unaudited): Global Annual sales AUD$7.3 million up 49% on prior yearJune 2025 Quarter AUD$2.0 million up 55% on...
Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement
ROCKVILLE, Md. and SUZHOU, China, July 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage...
Dogecoin Cash Inc. (OTCQB: DOGP) Reports Preparation of Provisional Patent Application for “Dogecoin Protocol” Architecture
Company evaluating technical architecture intended to support interoperability and programmability for DogecoinMesquite, NV, July 17, 2025 (GLOBE NEWSWIRE) -- Dogecoin...
EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology
Entrance of the EAACI Congress 2025, SEC in Glasgow Entrance of the EAACI Congress in the SEC located in Glasgow...
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
Leiden, the Netherlands, July 17, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary...